Ubs Asset Management Americas Inc Voyager Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$4.94 - $6.61 $241,566 - $323,229	48,900 New	48,900 $298,000
Q2 2021 Aug 16, 2021	SELL	$3.94 - $5.44 $103,350 - $142,696	-26,231 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$4.61 - $9.04 $56,343 - $110,486	12,222 Added 87.24%	26,231 $123,000
Q1 2020 May 15, 2020	SELL	$6.8 - $14.66 $1.9 Million - $4.1 Million	-279,967 Reduced 95.23%	14,009 $128,000
Q4 2019 Feb 14, 2020	SELL	$12.82 - $16.85 $242,874 - $319,223	-18,945 Reduced 6.05%	293,976 $4.1 Million
Q3 2019 Nov 14, 2019	BUY	$16.31 - $28.29 $46,304 - $80,315	2,839 Added 0.92%	312,921 $5.39 Million
Q2 2019 Aug 15, 2019	BUY	$19.18 - $27.88 $204,995 - $297,981	10,688 Added 3.57%	310,082 $0
Q1 2019 May 14, 2019	SELL	$8.0 - $19.66 $108,040 - $265,508	-13,505 Reduced 4.32%	299,394 $0
Q4 2018 Feb 13, 2019	SELL	$8.59 - $18.05 $195,611 - $411,034	-22,772 Reduced 6.78%	312,899 $2.94 Million
Q3 2018 Nov 14, 2018	BUY	$17.11 - $21.74 $134,159 - $170,463	7,841 Added 2.39%	335,671 $0
Q2 2018 Aug 14, 2018	BUY	$16.76 - $23.92 $1.02 Million - $1.45 Million	60,728 Added 22.74%	327,830 $0
Q1 2018 May 14, 2018	SELL	$16.16 - $31.31 $17,016 - $32,969	-1,053 Reduced 0.39%	267,102 $0
Q4 2017 Feb 09, 2018	BUY	$12.26 - $25.88 $3.29 Million - $6.94 Million	268,155	268,155 $0

130

34.7M

39.7K

34.6K

Ticker VYGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,647,600
Market Cap $223M
Description
Voyager Therapeutics, Inc., a gene therapy company, focuses on the development of treatments and next-generation platform technologies. The company's lead clinical candidate is the VY-AADC, which is in open-label Phase 1 clinical trial for the treatment of Parkinson's disease. Its preclinical programs comprise VY-SOD102 for the treatment of amyo...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.